SM
DXCM icon

Stephen Mandel’s DexCom DXCM Stock Holding History

Stephen Mandel’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,764,908
Closed -$788M – 33
2021
Q3 		$788M Sell
5,764,908
-1,708,240
-23% -$215M 2.66% 19
2021
Q2 		$798M Sell
7,473,148
-2,019,444
-21% -$194M 2.57% 18
2021
Q1 		$853M Buy
9,492,592
+421,356
+5% +$39.6M 3.1% 14
2020
Q4 		$838M Buy
9,071,236
+7,218,888
+390% +$645M 3.05% 15
2020
Q3 		$191M Buy
1,852,348
+494,164
+36% +$51.6M 0.82% 28
2020
Q2 		$138M Buy
+1,358,184
New +$121M 0.7% 26
2020
Q1 		– Sell
-4,235,580
Closed -$232M – 44
2019
Q4 		$232M Buy
+4,235,580
New +$201M 1.23% 29

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stephen Mandel's DXCM Position: Q4 2021 in Review

Stephen Mandel sold out of DexCom (DXCM) in Q4 2021, closing a stake of 5,764,908 shares — an estimated $788M sold.

Stephen Mandel first reported a position in DXCM in Q4 2019 and held it in 7 quarters. The position peaked at $853M in Q1 2021. 931 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • Stephen Mandel reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
  • Stephen Mandel sold 5,764,908 DexCom shares in Q4 2021, an estimated $788M.
  • Stephen Mandel first reported a position in DexCom in Q4 2019 and held it in 7 quarters.
  • Stephen Mandel's DexCom position peaked at $853M in Q1 2021.
  • 931 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on Lone Pine Capital's 13F filing for Q4 2021, filed 14 Feb 2022.